JP2004529953A5 - - Google Patents

Download PDF

Info

Publication number
JP2004529953A5
JP2004529953A5 JP2002588987A JP2002588987A JP2004529953A5 JP 2004529953 A5 JP2004529953 A5 JP 2004529953A5 JP 2002588987 A JP2002588987 A JP 2002588987A JP 2002588987 A JP2002588987 A JP 2002588987A JP 2004529953 A5 JP2004529953 A5 JP 2004529953A5
Authority
JP
Japan
Prior art keywords
compound
coona
formula
alkyl
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002588987A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004529953A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/015211 external-priority patent/WO2002092070A1/en
Publication of JP2004529953A publication Critical patent/JP2004529953A/ja
Publication of JP2004529953A5 publication Critical patent/JP2004529953A5/ja
Pending legal-status Critical Current

Links

JP2002588987A 2001-05-11 2002-05-13 浸透促進剤としてのイソステアリン酸塩 Pending JP2004529953A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29043701P 2001-05-11 2001-05-11
PCT/US2002/015211 WO2002092070A1 (en) 2001-05-11 2002-05-13 Isostearic acid salts as permeation enhancers

Publications (2)

Publication Number Publication Date
JP2004529953A JP2004529953A (ja) 2004-09-30
JP2004529953A5 true JP2004529953A5 (enExample) 2005-12-22

Family

ID=23115994

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002588987A Pending JP2004529953A (ja) 2001-05-11 2002-05-13 浸透促進剤としてのイソステアリン酸塩

Country Status (5)

Country Link
US (1) US20030018085A1 (enExample)
EP (1) EP1390024A4 (enExample)
JP (1) JP2004529953A (enExample)
CA (1) CA2446622C (enExample)
WO (1) WO2002092070A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
WO2002092069A1 (en) 2001-05-11 2002-11-21 Elan Corporation, Plc Permeation enhancers
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US20070196452A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Flux-enabling compositions and methods for dermal delivery of drugs
US20070196325A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for dermally treating infections
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
ES2399763T3 (es) 2005-10-12 2013-04-03 Unimed Pharmaceuticals, Llc Gel de testosterona mejorado y método de utilización
AU2007235251B2 (en) 2006-04-07 2013-02-07 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
BRPI0912384A2 (pt) 2008-05-07 2015-10-13 Merrion Res Iii Ltd composição, e, método para preparar uma composição
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
EP3250191B1 (en) 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
DE3331009A1 (de) * 1983-08-27 1985-03-14 Basf Ag, 6700 Ludwigshafen Verfahren zur erhoehung der enteralen resorbierbarkeit von heparin bzw. heparinoiden sowie das so erhaeltliche heparin- bzw. heparinoidpraeparat
JPS61200904A (ja) * 1985-03-04 1986-09-05 Shiseido Co Ltd 外用尿素製剤
US5190748A (en) * 1988-11-22 1993-03-02 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
IL92537A (en) * 1988-12-15 1994-04-12 Riker Laboratories Inc Topical preparations and dermal systems containing 1-isobutyl-H1-imidazo [C-4,5] quinoline-4-amine
JPH02207018A (ja) * 1989-02-07 1990-08-16 Kao Corp 皮膚外用剤
AU8219191A (en) * 1990-06-14 1992-01-07 Kalmo Enterprises, Inc. Stable aqueous drug suspensions
US5541155A (en) * 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
SE9302135D0 (sv) * 1993-06-18 1993-06-18 Kabi Pharmacia Ab New pharmaceutical composition
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
EP0827402A2 (en) * 1995-05-17 1998-03-11 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
GB9516268D0 (en) * 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
DE69910183T2 (de) * 1998-03-11 2004-06-03 Grelan Pharmaceutical Co., Ltd., Hamura Darmlösliche sprudelnde zusammensetzungen
CA2323101A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Skin moisturizing compositions
GB9814062D0 (en) * 1998-06-29 1998-08-26 Procter & Gamble Hair shampoo and conditioner system
NZ512628A (en) * 1999-01-08 2004-03-26 3M Innovative Properties Co Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
WO2002092069A1 (en) * 2001-05-11 2002-11-21 Elan Corporation, Plc Permeation enhancers

Similar Documents

Publication Publication Date Title
JP2004529953A5 (enExample)
JP2004533444A5 (enExample)
JP2004537516A5 (enExample)
JP2005532287A5 (enExample)
JP2002502874A5 (enExample)
EP1325921A3 (en) Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
JP2002513668A5 (enExample)
JP2005533804A5 (enExample)
CA2494049A1 (en) Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
JP2002512243A5 (enExample)
JP2003519676A5 (enExample)
RU96101139A (ru) Новые производные эритромицина, способ их получения и применение в качестве лекарственных средств
JP2005511699A5 (enExample)
JP2007516286A5 (enExample)
JP2007510662A5 (enExample)
JP2004131511A5 (enExample)
JP2007500734A5 (enExample)
CA2446622A1 (en) Isostearic acid salts as permeation enhancers
JP2008545718A5 (enExample)
JP2007532627A5 (enExample)
JP2006518788A5 (enExample)
RU2000125889A (ru) Замещенные бисиндолималеимиды, предназначенные для ингибирования пролиферации клеток
ATE231850T1 (de) Isochroman verbindungen und verfahren zu deren produktion
RU2222532C2 (ru) Соединения ряда бензофуроксана, способ их получения (варианты), фармацевтическая композиция, способ получения парентерального состава и способ лечения коронарных сердечных заболеваний
JP2006518765A5 (enExample)